eFFECTOR Therapeutics

0 followers


eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).

Industries

Employees

11-50

Links

This is an unverified company page

Org chart

Steve Worland
President & CEO
Collapse
Doug Warner
Chief Medical Officer
Gary Chiang
VP, Translational Science
Katie Ard
Director of Development Operations
Thomas Kevin Gregorczyk
Senior Director, Development Operations

Board & advisors


Teams


Offices